These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficiency of antisense oligonucleotide drug discovery. Bennett CF Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):215-24. PubMed ID: 12162703 [TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide technology: from EST to therapeutics. Giles RV Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides as therapeutics for malignant diseases. Ho PT; Parkinson DR Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides. Herdewijn P Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554 [TBL] [Abstract][Full Text] [Related]
10. [Synthetic oligonucleotides and their application in gene therapy]. Iribarren AM Medicina (B Aires); 1995; 55(3):263-6. PubMed ID: 8544726 [TBL] [Abstract][Full Text] [Related]
11. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests. AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558 [No Abstract] [Full Text] [Related]
12. Intranasal antisense therapy: preclinical models with a clinical future? Bitko V; Barik S Curr Opin Mol Ther; 2007 Apr; 9(2):119-25. PubMed ID: 17458164 [TBL] [Abstract][Full Text] [Related]
13. [Antisense oligonucleotides: a new class of biologically active molecules]. Uteshev DB; Korostelev SA; Sergeev AV; Uteshev BS Eksp Klin Farmakol; 2004; 67(3):76-9. PubMed ID: 15341077 [TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method. Yildiz D; Oztas H; Hilal Ates B Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566 [TBL] [Abstract][Full Text] [Related]
15. Liposomal antisense oligonucleotides for cancer therapy. Siwak DR; Tari AM; Lopez-Berestein G Methods Enzymol; 2004; 387():241-53. PubMed ID: 15172168 [No Abstract] [Full Text] [Related]
16. QC in antisense oligo synthesis. Agris PF; Smith S; Fu C; Simkins SG Nat Biotechnol; 2002 Sep; 20(9):871-2. PubMed ID: 12205500 [No Abstract] [Full Text] [Related]